Article Citation
Zhou J, Chen JR, Li JM, Han SQ, Deng XY, Li ZM, Tong W, Wang C, Bai Y, Zhang YM. IL-22/IL-22R1 pathway enhances cholangiocarcinoma progression via ERK1/2 activation. World J Gastrointest Oncol 2025; 17(3): 102083 [PMID: 40092929 DOI: 10.4251/wjgo.v17.i3.102083]
Please LOGIN to submit a new comment.